FDA Inspection 1109738 — Asentral Inc. IRB
The FDA completed an inspection of Asentral Inc. IRB on October 24, 2019 in Newburyport, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2019
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Newburyport, MA (United States)
Additional Details
IRB